Professor Keith Harding
Projects as PI
- A 6 month prospective, randomized, double blind, placebo-controlled, parallel group, multiple centre trial to evaluate the efficacy and safety of fragmin in the treatment of chronic neuroischaemic foot ulcers in diabetic patients (17/06/2008 - 31/12/2010)
- Agreement between the Wound Healing Research Unit and 3M Laboratories (Europe) Ltd - Skin Care Agreement (01/05/2001 - 30/11/2009)
- A method for sampling wounds for exudate, enabling remote diagnosis of protease and other biological component activity in chronic wounds (01/09/2009 - 31/01/2012)
- An open prospective randomised multi-centre clinical evaluation to compare ALLEVYN gentle border with Mepilex border in the management of exuding chronic and acute wounds (22/04/2009 - 21/04/2011)
- An open randomised comparative study to evaluate the performance of aquacel extra in venous leg ulcers (01/04/2012 - 31/10/2012)
Projects as Co-Investigator
- Accelerate East (01/06/2018 - 31/12/2022)
- Accelerate West (01/06/2018 - 31/12/2022)
- Controlled and targeted delivery of potassium permanganate microparticles to wounds utilising the Permipatch technology (13/09/2015 - 31/08/2016)
- Development of a chemiluminescent-based test for miR-21 to investigate its potential as a diagnostic marker in chronic wound management (01/08/2014 - 31/08/2015)
- Development of a wound healing prognostic indicator (01/01/2011 - 31/07/2012)